Chenglong Li

694 total citations
20 papers, 527 citations indexed

About

Chenglong Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chenglong Li has authored 20 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Chenglong Li's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (4 papers). Chenglong Li is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (4 papers). Chenglong Li collaborates with scholars based in China, United States and Germany. Chenglong Li's co-authors include Yan Liu, Jiayuh Lin, Qingyou Meng, James R. Fuchs, Aimin Qian, Wendong Li, Wenbin Wang, Liping Su, Ming Wang and Beiqin Yu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Acta Biomaterialia.

In The Last Decade

Chenglong Li

19 papers receiving 520 citations

Peers

Chenglong Li
Qun Lv China
Haijun Lu China
Zhi‐Dong Lv China
Xigan He China
Guanghai Dai China
Hansi Liang China
Bingjie Guan China
Ruirong Xu China
Qun Lv China
Chenglong Li
Citations per year, relative to Chenglong Li Chenglong Li (= 1×) peers Qun Lv

Countries citing papers authored by Chenglong Li

Since Specialization
Citations

This map shows the geographic impact of Chenglong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglong Li more than expected).

Fields of papers citing papers by Chenglong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenglong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglong Li. The network helps show where Chenglong Li may publish in the future.

Co-authorship network of co-authors of Chenglong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chenglong Li. A scholar is included among the top collaborators of Chenglong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenglong Li. Chenglong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Manman, Yihua Zhang, Sirui Li, et al.. (2025). ID1 boosts antiviral immunity by countering PRMT5-mediated STING methylation. Cell Reports. 44(11). 116547–116547. 1 indexed citations
2.
Shang, Yanhong, et al.. (2025). A novel lysin Ply691 exhibits potent bactericidal activity against Streptococcus suis. Frontiers in Veterinary Science. 12. 1653748–1653748.
3.
Li, Wen‐Jun, Shengxiang Ge, Yong Liu, et al.. (2025). Characterization of lincomycin resistance gene lnu(C)-carrying Campylobacter jejuni. Veterinary Microbiology. 310. 110707–110707. 1 indexed citations
4.
5.
Shan, Xinxin, Chenglong Li, Chenhui Zou, et al.. (2024). poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis. Journal of Antimicrobial Chemotherapy. 79(12). 3199–3203. 4 indexed citations
6.
Li, Chenglong, et al.. (2023). Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development. World Journal of Gastrointestinal Oncology. 15(10). 1717–1738. 5 indexed citations
7.
Su, Zhe, et al.. (2023). Identification and immune features of cuproptosis-related molecular clusters in polycystic ovary syndrome. Scientific Reports. 13(1). 980–980. 9 indexed citations
8.
Li, Chenglong, et al.. (2023). MiR-132-3p activation aggravates renal ischemia-reperfusion injury by targeting Sirt1/PGC1alpha axis. Cellular Signalling. 110. 110801–110801. 14 indexed citations
9.
Wu, Chen, Xing Ji, Kang Chen, et al.. (2023). SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53. Cancer Cell International. 23(1). 221–221. 8 indexed citations
10.
Li, Chenglong, et al.. (2022). Over-expression of NFYB affects stromal cells reprogramming and predicts worse survival in gastric cancer patients. Aging. 14(19). 7851–7865. 4 indexed citations
11.
Shi, Lang, et al.. (2021). MiR-150-5p protects against septic acute kidney injury via repressing the MEKK3/JNK pathway. Cellular Signalling. 86. 110101–110101. 40 indexed citations
12.
Li, Chenglong, Li Deng, Qiaoming Zhi, et al.. (2015). MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer. Anti-Cancer Agents in Medicinal Chemistry. 16(4). 447–455. 24 indexed citations
13.
Meng, Qingyou, Wenbin Wang, Xiaobin Yu, et al.. (2015). Upregulation of MicroRNA‐126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis via Its Target PIK3R2. Journal of Cellular Biochemistry. 116(8). 1613–1623. 59 indexed citations
14.
Wang, Wenbin, Chenglong Li, Wendong Li, et al.. (2014). MiR-150 enhances the motility of EPCs in vitro and promotes EPCs homing and thrombus resolving in vivo. Thrombosis Research. 133(4). 590–598. 47 indexed citations
15.
Zhao, Yu, Chenglong Li, Ming Wang, et al.. (2013). Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer. PLoS ONE. 8(7). e69756–e69756. 69 indexed citations
16.
Rao, Wei, Wujie Zhang, Yifeng Lei, et al.. (2013). Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction. Acta Biomaterialia. 10(2). 831–842. 61 indexed citations
17.
Li, Chenglong, Hui Nie, Ming Wang, et al.. (2012). MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Letters. 320(2). 189–197. 72 indexed citations
18.
Liu, Aiguo, Yan Liu, Pui‐Kai Li, Chenglong Li, & Jiayuh Lin. (2011). LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.. PubMed. 31(6). 2029–35. 27 indexed citations
19.
Liu, Yan, James R. Fuchs, Chenglong Li, & Jiayuh Lin. (2010). IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-Induced STAT3 phosphorylation in human hepatocellular cancer cells. Cell Cycle. 9(17). 3423–3427. 62 indexed citations
20.
Ely, Kathryn R. & Chenglong Li. (2002). Structurally adaptive hot spots at a protein interaction interface on TRAF3. Journal of Molecular Recognition. 15(5). 286–290. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qun Lv Breakdown of academic impact, for papers by Haijun Lu Breakdown of academic impact, for papers by Zhi‐Dong Lv Breakdown of academic impact, for papers by Xigan He Breakdown of academic impact, for papers by Guanghai Dai Breakdown of academic impact, for papers by Hansi Liang Breakdown of academic impact, for papers by Bingjie Guan Breakdown of academic impact, for papers by Ruirong Xu
Rankless by CCL
2026